Download
s40348-021-00118-8.pdf 339,12KB
WeightNameValue
1000 Titel
  • Novel ways to monitor immunosuppression in pediatric kidney transplant recipients—underlying concepts and emerging data
1000 Autor/in
  1. Ahlenstiel-Grunow, Thurid |
  2. Pape, Lars |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-26
1000 Erschienen in
1000 Quellenangabe
  • 8(1):8
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40348-021-00118-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313639/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • After pediatric kidney transplantation, immunosuppressive therapy is given to avoid acute and chronic rejections. However, the immunosuppression causes an increased risk of severe viral complications and bacterial infections and is associated with serious side effects. It is therefore crucial to achieve the optimal individual balance between over- and under-immunosuppression and thereby avoid unnecessary exposure to immunosuppressive drugs. In routine use, steering of immunosuppressants is performed primarily by monitoring of trough levels that mirror pharmacokinetics (although not, however, pharmacodynamics). Other diagnostic and prognostic markers to assess the individual intensity of immunosuppression are missing. Potential methods to determine immune function and grade of immunosuppression, such as analysis of the torque teno virus (TTV) load, QuantiFERON Monitor®, and ImmuKnow® as well as virus-specific T cells (Tvis), are currently being evaluated. In some studies TTV load, QuantiFERON Monitor® and ImmuKnow® were associated with the risk for post-transplant rejections and infections, but randomized controlled trials after pediatric kidney transplantation are not available. Post-transplant monitoring of Tvis levels seem to be promising because Tvis control virus replication and have been shown to correlate with virus-specific as well as general cellular immune defense, which represents the individual's susceptibility to infections. Additional Tvis-monitoring provides an innovative opportunity to personalize the antiviral management and the dosing of the immunosuppressive therapy after pediatric kidney transplantation to avoid unnecessary therapeutic interventions and identify over-immunosuppression.
1000 Sacherschließung
lokal Mechanism of kidney disease development and CKD associated morbidities
lokal Biomarkers
lokal Immune monitoring
lokal Kidney transplantation
lokal Pediatric transplantation
lokal Mini Review
lokal Immunosuppression
lokal Virus-specific T cells
lokal Viral infections
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QWhsZW5zdGllbC1HcnVub3csIFRodXJpZA==|https://orcid.org/0000-0002-3635-6418
1000 Hinweis
  • DeepGreen-ID: 4ec1c17b3ff7481d963a909d9382e463 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6442182.rdf
1000 Erstellt am 2023-04-26T13:23:52.229+0200
1000 Erstellt von 322
1000 beschreibt frl:6442182
1000 Zuletzt bearbeitet 2023-10-19T11:59:24.342+0200
1000 Objekt bearb. Thu Oct 19 11:59:24 CEST 2023
1000 Vgl. frl:6442182
1000 Oai Id
  1. oai:frl.publisso.de:frl:6442182 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source